Sign in to view content

Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies

Chirag D. Jhaveri, MD, FASRS

Video
Published 2020

Related

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2020
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO
Suber S. Huang, MD, MBA, FASRS
Annual Meeting Talks
2021
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies
Robert L. Avery, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more